Unknown

Dataset Information

0

Functional Characteristics and Phenotypic Plasticity of CD57+PD1- CD4 T Cells and Their Relationship with Transplant Immunosuppression.


ABSTRACT: Costimulation blockade (CoB)-based immunosuppression offers the promise of improved transplantation outcomes with reduced drug toxicity. However, it is hampered by early acute rejections, mediated at least in part by differentiated, CoB-resistant T cells, such as CD57+PD1- CD4 T cells. In this study, we characterize these cells pretransplant, determine their fate posttransplant, and examine their proliferative capacity in vitro in humans. Our studies show that CD57+PD1- CD4 T cells are correlated with increasing age and CMV infection pretransplant, and persist for up to 1 y posttransplant. These cells are replication incompetent alone but proliferated in the presence of unsorted PBMCs in a contact-independent manner. When stimulated, cells sorted by CD57/PD1 status upregulate markers of activation with proliferation. Up to 85% of CD57+PD1- cells change expression of CD57/PD1 with stimulation, typically, upregulating PD1 and downregulating CD57. PD1 upregulation is accentuated in the presence of rapamycin but prevented by tacrolimus. These data support a general theory of CoB-resistant cells as Ag-experienced, costimulation-independent cells and suggest a mechanism for the synergy of belatacept and rapamycin, with increased expression of the activation marker PD1 potentiating exhaustion of CoB-resistant cells.

SUBMITTER: Shaw BI 

PROVIDER: S-EPMC7987798 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functional Characteristics and Phenotypic Plasticity of CD57<sup>+</sup>PD1<sup>-</sup> CD4 T Cells and Their Relationship with Transplant Immunosuppression.

Shaw Brian I BI   Espinosa Jaclyn R JR   Stempora Linda L   Miller Allison A   Adams Bartley B   Kirk Allan D AD  

Journal of immunology (Baltimore, Md. : 1950) 20210217 7


Costimulation blockade (CoB)-based immunosuppression offers the promise of improved transplantation outcomes with reduced drug toxicity. However, it is hampered by early acute rejections, mediated at least in part by differentiated, CoB-resistant T cells, such as CD57<sup>+</sup>PD1<sup>-</sup> CD4 T cells. In this study, we characterize these cells pretransplant, determine their fate posttransplant, and examine their proliferative capacity in vitro in humans. Our studies show that CD57<sup>+</s  ...[more]

Similar Datasets

2016-01-08 | E-GEOD-64805 | biostudies-arrayexpress
2016-01-08 | GSE64805 | GEO
| S-EPMC11336540 | biostudies-literature
| S-EPMC8718626 | biostudies-literature
| S-EPMC7315224 | biostudies-literature
| S-EPMC7079235 | biostudies-literature
| S-EPMC4637038 | biostudies-literature
| S-EPMC11298341 | biostudies-literature
| S-EPMC10142381 | biostudies-literature
| S-EPMC5334526 | biostudies-literature